Evidence map›Paper›PMID 27010636›Full record

ArticlePLoS pathogens2016

The Lymphocytic Choriomeningitis Virus Matrix Protein PPXY Late Domain Drives the Production of Defective Interfering Particles.

Christopher M Ziegler, Philip Eisenhauer, Emily A Bruce, Marion E Weir, Benjamin R King, Joseph P Klaus, Dimitry N Krementsov, David J Shirley, Bryan A Ballif, Jason Botten

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Emergency Services of Viral RNAs: Repair and Remodeling.Microbiology and molecular biology reviews : MMBR · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Christopher M ZieglerDepartment of Medicine, Division of Immunobiology, University of Vermont, Burlington, Vermont, United States of America.
Philip EisenhauerDepartment of Medicine, Division of Immunobiology, University of Vermont, Burlington, Vermont, United States of America.
Emily A BruceDepartment of Medicine, Division of Immunobiology, University of Vermont, Burlington, Vermont, United States of America.
Marion E WeirDepartment of Biology, University of Vermont, Burlington, Vermont, United States of America.
Benjamin R KingDepartment of Medicine, Division of Immunobiology, University of Vermont, Burlington, Vermont, United States of America.
Joseph P KlausDepartment of Medicine, Division of Immunobiology, University of Vermont, Burlington, Vermont, United States of America.
Dimitry N KrementsovDepartment of Medicine, Division of Immunobiology, University of Vermont, Burlington, Vermont, United States of America.
David J ShirleyDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, United States of America.
Bryan A BallifDepartment of Biology, University of Vermont, Burlington, Vermont, United States of America.
Jason BottenDepartment of Medicine, Division of Immunobiology, University of Vermont, Burlington, Vermont, United States of America.
University of Vermont · US

Funding

Vaccines and Diagnostics TrialsU54AI065359 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI BARBOUR, ALAN G. · 2005 to 2013
$88.8M
Vermont INBRE Administrative Supplement 2024 AWD 118P20GM103449 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI CHRISTOPHER S FRANCKLYN · 2012 to 2026
$58.4M
VERMONT IMMUNOBIOLOIGY/ INFECTIOUS DISEASES CENTERP20RR021905 · NCRR · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HILL, JACK · 2006 to 2011
$14.5M
Multidisciplinary Training in Lung BiologyT32HL076122 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI IRVIN, CHARLES G, POYNTER, MATTHEW E · 2004 to 2023
$6.1M
Vermont Immunology/Infectious Diseases Training GrantT32AI055402 · NIAID · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI GARY E WARD · 2005 to 2026
$2.7M
Identification of Novel Arenavirus Protein-Host Cellular Protein InteractionsR21AI088059 · NIAID · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BOTTEN, JASON W. · 2010 to 2011
$416k
NCRR NIH HHS P20 RR021905NCRR NIH HHS P20RR021905NHLBI NIH HHS T32 HL076122NIAID NIH HHS AI065359NIAID NIH HHS R21 AI088059NIAID NIH HHS T32 AI055402NIAID NIH HHS U54 AI065359NIGMS NIH HHS 8P20GM103449NIGMS NIH HHS P20 GM103449
6 · The paper itself

Abstract

Arenaviruses cause severe diseases in humans but establish asymptomatic, lifelong infections in rodent reservoirs. Persistently-infected rodents harbor high levels of defective interfering (DI) particles, which are thought to be important for establishing persistence and mitigating virus-induced cytopathic effect. Little is known about what drives the production of DI particles. We show that neither the PPXY late domain encoded within the lymphocytic choriomeningitis virus (LCMV) matrix protein nor a functional endosomal sorting complex transport (ESCRT) pathway is absolutely required for the generation of standard infectious virus particles. In contrast, DI particle release critically requires the PPXY late domain and is ESCRT-dependent. Additionally, the terminal tyrosine in the PPXY motif is reversibly phosphorylated and our findings indicate that this posttranslational modification may regulate DI particle formation. Thus we have uncovered a new role for the PPXY late domain and a possible mechanism for its regulation.

Indexed as

Cell LineDefective VirusesEndosomal Sorting Complexes Required for TransportEndosomesHumansLymphocytic choriomeningitis virusPhosphorylationProtein Structure, TertiaryVirionVirus ReleaseEndosomal Sorting Complexes Required for Transport

Identifiers

PMID27010636
PMCPMC4806877
OpenAlexW2311934927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.